title: Does growth hormone therapy induce IgA nephropathy?
authors.forename: Kenichi
authors.initials: K
authors.lastname: Kano
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Nishikura
authors.forename: Osamu
authors.initials: O
authors.lastname: Arisaka
mesh_terms: D002675:Child, Preschool; D004176:Dipyridamole / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D005922:Glomerulonephritis, IGA / Q000188:drug therapy / Q000209:etiology*; D013006:Growth Hormone / Q000009:adverse effects*; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D008297:Male; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007070:Immunoglobulin A; D011994:Recombinant Proteins; D004176:Dipyridamole; D013006:Growth Hormone